Insider Trading (Form 4)
NYSE
Chris Lavictoire Mahai, a Director of abrdn Healthcare Opportunities Fund, purchased 568 shares of common stock on July 16, 2026 for $18.49 per share.
NYSE
Director Rose DiMartino purchased 1,000 shares of abrdn Healthcare Opportunities Fund (THQ) at $21.30 per share on July 16, 2024.
NYSE
Director Kathleen Goetz purchased 600 shares of abrdn Healthcare Opportunities Fund (THQ) at a price of $19.5381 per share on April 9, 2024, increasing her direct holdings to 1,148.188 shares.
Proxy Statements (Def-14A)
NYSE
Abrdn Healthcare Investors, Abrdn Life Sciences Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund have issued a joint proxy statement detailing their upcoming annual shareholder meetings on May 27, 2026, primarily for the election of Trustees.
NYSE
Abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund will hold annual shareholder meetings on May 28, 2025, to elect trustees.
NYSE
Abrdn Healthcare Investors, Abrdn Healthcare Opportunities Fund, and Abrdn World Healthcare Fund will hold annual shareholder meetings on June 25, 2024, to elect trustees.